Naurex Logo
  • Home
  • About Us
  • R&D
  • Resources
  • News
  • Contact Us

      
  •  
  • Home > News

    News

  • News

  • Press Releases

    August 31, 2010
    Naurex’s Novel Antidepressant Glyx-13 Recognized as One of Windhover's Top 10 Neuroscience Projects to Watch
    June 17, 2010
    Naurex Inc. Presents Positive Clinical Data on Novel Mechanism Antidepressant Candidate Glyx-13 at NCDEU 50th Anniversary Meeting
    February 11, 2010
    Naurex Inc. Reports Positive Top-Line Phase I Results for its Novel Mechanism NMDA Receptor Modulator GLYX-13 in Treatment-Resistant Depression
    December 16, 2009
    Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity with No Signs of Classic NMDA-Associated Side Effects
    December 16, 2009
    Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression

    Naurex in the News

    Naurex Opens the Therapeutic Window for NMDA Modulators, December 29, 2009 – BioWorld Today

    Naurex Launches Trial, Looks For Series A, November 17, 2009 – DowJones VentureWire Lifescience
  • Home | 
  • About Us |  
  • R&D | 
  • Resources | 
  • News | 
  • Contact Us

Website and Contents Copyright © Naurex, Inc.